Neervannan Seshadri
SEC insider (Form 3/4/5 filer). CIK 0001827584. Chief Operating Officer at Tarsus Pharmaceuticals, Inc. (TARS). 17 reported Form 4/5 transactions since Sep 2024; latest on Sep 4, 2026. Located in IRVINE, CA.
Companies Neervannan Seshadri has filed insider reports for
- Tarsus Pharmaceuticals, Inc. (TARS): Officer, Chief Operating Officer
Neervannan Seshadri
CIK: 0001827584
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tarsus Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect4.6K shares at avg. $85.00$388K - Mar 20, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect3K shares at avg. $66.75$200K - Mar 19, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect4.6K shares at avg. $67.00$307K - Mar 18, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect3.6K shares at avg. $68.71$248K - Mar 17, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect3.1K shares at avg. $69.42$217K - Mar 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect26.3K shares- - Mar 5, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
17.2K shares- - Mar 5, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
27.3K shares- - Mar 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect8.4K shares at avg. $76.67$641K - Dec 16, 2025TARS
Tarsus Pharmaceuticals, Inc.
GiftDirect950 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,564 | $85.00 | $387,940 | Direct |
| Mar 20, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 2,989 | $66.75 | $199,516 | Direct |
| Mar 19, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,589 | $67.00 | $307,463 | Direct |
| Mar 18, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 3,610 | $68.71 | $248,043 | Direct |
| Mar 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 3,125 | $69.42 | $216,938 | Direct |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise | 26,287 | - | $0 | Direct |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Restricted Stock Units | 17,161 | - | - | Direct |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 27,310 | - | - | Direct |
| Mar 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 8,366 | $76.67 | $641,421 | Direct |
| Dec 16, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Gift | 950 | - | - | Direct |
1-10 of 17 transactions